What finance podcasts are saying aboutApogee Therapeutics, Inc.APGENasdaq
According to Zortix's podcast index, Apogee Therapeutics, Inc. (APGE) has 2 attributed ideas on record from finance podcasts, but none aired in the 30 days to 27 Aug 2026.
- Mentions · 7d
- 0
- Mentions · 30d
- 0
- Mentions · 90d
- 2
- Episodes · 30d
- 0
- Shows · 30d
- 0
- Vs prior week
- 0
- Discussion depth
- Core-thesis conviction
As of 28 Jul 2026
Ask Zortix about APGEKey facts
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- San Francisco, CA
- Fiscal year ends
- 31 December
- Formerly
- Apogee Therapeutics, LLC
Listing and registration facts from public registries · SEC EDGAR filings for APGE. Not a rating, forecast or recommendation.
Stance mix · podcast discussion
No attributed discussion in this window.
15 JUNWEEKLY · 90D22 JUN
Counts of attributed podcast discussion · not a rating, forecast, or recommendation
Latest ideas · headlines, attributed
22 JUN22 JUNCNBC FAST MONEY · GOOGLE
18 JUN18 JUNCNBC FAST MONEY
Definitions
- Mention
- One attributed idea naming this ticker, extracted from a podcast episode and dated by the episode’s air date. How we count →
- Attributed idea
- A specific argument a named speaker made on a named show — never an aggregate opinion, never Zortix’s view. What qualifies →
- Discussion depth
- How thoroughly an idea was argued on the episode, from a brief mention to a core thesis — a description of the conversation, not a rating of the stock. The bands →
- Stance mix
- Counts of attributed ideas by the side each argued on this name — bullish, balanced, or bearish as the speaker put it. A tally of the conversation’s sides, never a combined score, a rating, or Zortix’s view.